Research & Development

Flavonoids Show Promise in GI Cancer Treatment via Ferroptosis
Research & Development Flavonoids Show Promise in GI Cancer Treatment via Ferroptosis

In a world where gastrointestinal (GI) cancers continue to pose a formidable challenge to global health, a groundbreaking study from researchers at Weill Cornell Medicine-Qatar has unveiled a potential game-changer in cancer therapy. GI cancers, encompassing colorectal, stomach, liver, esophageal,

Can Miricorilant Revolutionize MASH Treatment in Trials?
Research & Development Can Miricorilant Revolutionize MASH Treatment in Trials?

In the realm of liver disease research, metabolic-associated steatohepatitis (MASH), a severe form of fatty liver disease also known as metabolic dysfunction-associated steatotic liver disease (MASLD), stands as a formidable challenge with potentially devastating consequences. Characterized by

How Do At-Home Tests Boost Colorectal Cancer Screening?
Research & Development How Do At-Home Tests Boost Colorectal Cancer Screening?

Imagine a silent epidemic creeping into the lives of younger adults, where a deadly disease like colorectal cancer is becoming a leading cause of cancer-related deaths among men under 50 and the second leading cause among women in the same age group. Despite the U.S. Preventive Services Task Force

FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata
Research & Development FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata

Imagine waking up each day to find more hair on your pillow than on your scalp, a stark reminder of an unseen battle within your body that strips away confidence. Alopecia areata (AA), an autoimmune condition, affects nearly 700,000 individuals in the United States, causing unpredictable hair loss

Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?
Research & Development Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the realm of innovative technologies for neurological disorders. Today, we’re diving into the recent clinical trial results from Praxis Precision Medicines

Can U.S. Organ Transplant Reforms Restore Public Trust?
Research & Development Can U.S. Organ Transplant Reforms Restore Public Trust?

In a nation where thousands of lives hang in the balance awaiting organ transplants, the U.S. system has long been plagued by systemic failures that have eroded public confidence. Reports of operational flaws, lack of accountability, and even shocking practices—such as initiating organ donation

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later